{
    "clinical_study": {
        "@rank": "47178", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the effectiveness and safety of TLK286 given\n      intravenously once every week in the treatment of patients with advanced ovarian cancer that\n      is resistant to platinum-based chemotherapy."
        }, 
        "brief_title": "Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer", 
        "completion_date": {
            "#text": "July 2005", 
            "@type": "Actual"
        }, 
        "condition": "Ovarian Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Ovarian Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  Histologic diagnosis of ovarian cancer\n\n          -  Recurrent or persistent disease following primary therapy\n\n          -  Measurable disease\n\n          -  Prior treatment with at least one but no more than three prior chemotherapy regimens\n\n          -  Resistant or refractory to platinum-based chemotherapy\n\n          -  At least 18 years of age\n\n          -  Good performance status (ECOG 0 to 1)\n\n          -  Adequate liver, renal and bone marrow function\n\n        Exclusion criteria\n\n          -  Pregnant or currently breast feeding\n\n          -  Treatment with chemotherapy or immunotherapy within four weeks\n\n          -  Prior radiation to the whole pelvis"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "40", 
        "firstreceived_date": "May 30, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00038428", 
            "org_study_id": "TLK286.2003"
        }, 
        "intervention": {
            "intervention_name": "TLK286", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "July 21, 2011", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "USC/Norris Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "M.D. Anderson Cancer Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2005", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00038428"
        }, 
        "responsible_party": {
            "name_title": "Gail Brown, M.D. Chief Medical Officer", 
            "organization": "Telik, Inc."
        }, 
        "source": "Telik", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Telik", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2001", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2011"
    }, 
    "geocoordinates": {
        "M.D. Anderson Cancer Center": "29.76 -95.369", 
        "Memorial Sloan-Kettering Cancer Center": "40.714 -74.006", 
        "USC/Norris Comprehensive Cancer Center": "34.052 -118.244"
    }
}